Table 2.

Comparison of HbA1c values pre-comprehensive medication review (CMR) intervention and post-CMR intervention.

	Pre-CMR	Post-CMR	p-Value
Total population N = 444
HbA1c	N (%)	N (%)
<6.5%	130 (29)	151 (34)	<0.001
6.5–9.0%	234 (52)	227 (51)	<0.001
>9.0%	80 (18)	66 (15)	<0.001
HbA1c *	Median (range)	Median (range)	p-value
	7.4 (4.5–13.9)	7.1 (4.5–13.6)	0.009
Adults (40–64 years of age) N = 104
HbA1c	N (%)	N (%)
<6.5%	24 (23)	40 (38)	<0.001
6.5–9.0%	51 (49)	46 (44)	<0.001
>9.0%	29 (28)	18 (17)	<0.001
HbA1c *	Median (range)	Median (range)	p-value
	7.8 (4.8–13.2)	7.1 (4.5–12.1)	0.002
Elderly (65–75 years of age) N = 340
HbA1c	N (%)	N (%)
<6.5%	106 (31)	111 (33)	<0.001
6.5–9.0%	183 (54)	181 (53)	<0.001
>9.0%	51 (15)	48 (14)	<0.001
HbA1c *	Median (range)	Median (range)	p-value
	7.2 (4.5–13.9)	7.4 (5.0–13.6)	0.256

HbA1c: glycosylated hemoglobin; * HbA1c data had a skewed distribution, hence median and range were reported. Differences between the pre- and post-groups were calculated using the Wilcoxon signed-rank test given that the data were dependent (i.e., the same people were included in the pre- and post-groups).